Jaguar Health, Inc. financial data

Symbol
JAGX on Nasdaq
Location
200 Pine Street Suite 400, San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 131 % -32.9%
Quick Ratio 42.6 % -25.3%
Return On Equity -32.1 % -150%
Return On Assets -4.14 % -139%
Operating Margin -278 %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 28M USD +183%
Weighted Average Number of Shares Outstanding, Basic 1.01M shares -71.6%
Weighted Average Number of Shares Outstanding, Diluted 1.01M shares -71.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 11.8M USD +9.48%
Cost of Revenue 2.14M USD +3.98%
Research and Development Expense 15.6M USD -11.1%
Selling and Marketing Expense 9.69M USD +62.2%
General and Administrative Expense 17.3M USD +7.65%
Costs and Expenses 44.7M USD +6.48%
Operating Income (Loss) -32.8M USD -3.44%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -41.4M USD -14.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.19M USD -139%
Earnings Per Share, Basic -67 USD/shares -39.3%
Earnings Per Share, Diluted -67 USD/shares +97.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.21M USD -86.2%
Accounts Receivable, after Allowance for Credit Loss, Current 1.17M USD -9.7%
Inventory, Net 10.7M USD +12.2%
Assets, Current 27.9M USD -30.4%
Property, Plant and Equipment, Net 441K USD -9.63%
Operating Lease, Right-of-Use Asset 1.14M USD -3.23%
Intangible Assets, Net (Excluding Goodwill) 17.5M USD -9.6%
Assets 48.3M USD -21.5%
Accounts Payable, Current 6.62M USD +61.7%
Accrued Liabilities, Current 3.6M USD +7.91%
Contract with Customer, Liability, Current 170K USD 0%
Liabilities, Current 29.2M USD +52.7%
Contract with Customer, Liability, Noncurrent 468K USD -26.6%
Operating Lease, Liability, Noncurrent 960K USD +18.2%
Liabilities 41.4M USD -2.38%
Accumulated Other Comprehensive Income (Loss), Net of Tax -719K USD -32.7%
Retained Earnings (Accumulated Deficit) -367M USD -12.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.88M USD -58.5%
Liabilities and Equity 48.3M USD -21.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.32M USD -3.82%
Net Cash Provided by (Used in) Financing Activities 4.97M USD -59.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.31M USD -144%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.21M USD -86.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 6K USD -33.3%
Deferred Tax Assets, Valuation Allowance 93.6M USD +66.4%
Deferred Tax Assets, Gross 94.1M USD +63.3%
Operating Lease, Liability 1.22M USD -0.98%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -40.8M USD -15%
Lessee, Operating Lease, Liability, to be Paid 2.08M USD +6.82%
Property, Plant and Equipment, Gross 977K USD 0%
Operating Lease, Liability, Current 256K USD -38.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 374K USD +53.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 377K USD +8.96%
Operating Lease, Weighted Average Discount Rate, Percent 0.24 pure +20%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 867K USD +20.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 385K USD +63.1%
Deferred Tax Assets, Operating Loss Carryforwards 77.7M USD +49.9%
Preferred Stock, Shares Issued 381 shares +285%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 77K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 396K USD +63%
Operating Lease, Payments 63K USD -81.3%
Preferred Stock, Shares Outstanding 381 shares +285%
Amortization of Intangible Assets 1.91M USD -1.85%
Depreciation, Depletion and Amortization 479K USD -4.39%
Deferred Tax Assets, Net of Valuation Allowance 545K USD -61.4%
Share-based Payment Arrangement, Expense 1.26M USD -39.5%
Interest Expense -343K USD -127%